tiprankstipranks
Viracta Therapeutics (VIRX)
OTHER OTC:VIRX
US Market

Viracta Therapeutics (VIRX) Income Statement

Compare
928 Followers

Viracta Therapeutics Income Statement

Last quarter (Q3 2024), Viracta Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Viracta Therapeutics's net income was $-10.55M. See Viracta Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 0.00$ 0.00$ 0.00$ 120.00K$ 2.07M
Gross Profit
$ -492.00K$ -210.00K$ -178.00K$ 88.00K$ 2.07M
Operating Expenses
$ 50.69M$ 50.59M$ 25.80M$ 18.82M$ 25.36M
Depreciation and Amortization
$ 492.00K$ 210.00K$ 178.00K$ 32.00K$ 3.13K
EBITDA
$ -46.86M$ -48.41M$ -114.09M$ -18.77M$ -22.82M
Operating Income
$ -50.69M$ -50.59M$ 62.50M$ -18.82M$ -23.29M
Other Income/Expenses
$ -365.00K$ 1.39M$ -75.46M$ -202.00K$ -42.00K
Pretax Income
$ -51.06M$ -49.20M$ -114.76M$ -19.02M$ -23.33M
Net Income
$ -51.06M$ -49.77M$ -203.06M$ -19.20M$ -23.33M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -1.32$ -1.32$ -6.37$ -206.93$ -9.37
Diluted EPS
$ -1.32$ -1.32$ -6.37$ -206.93$ -9.37
Weighted Average Shares Outstanding
38.62M 37.79M 31.87M 92.78K 2.49M
Weighted Average Shares Outstanding (Diluted)
38.62M 37.79M 31.87M 92.78K 2.49M
Currency in USD

Viracta Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis